The Asia-Pacific Proteomics market is projected to grow at a CAGR of around 7.8% during the forecast period, i.e., 2023-28.                          

Key Findings of the Study: Asia-Pacific Proteomics Market

Asia-Pacific Proteomics Market Opportunity: Biomarker Discovery & Validation to Emerge as a Key Opportunity Area for Proteomics Testing

Biomarkers are measurable indicators that provide valuable information about normal or pathological processes, treatment response, and disease progression. Proteomics plays a crucial role in identifying, validating, and utilizing these biomarkers for various clinical applications, presenting significant growth opportunities in the field.

In order to harness the potential of biomarker identification, several biotechnology companies like Novo Nordisk & Biorad are making significant investments in proteomics technology to offer personalized biomarker therapy to patients. For instance:

In 2023, Novo Holdings invested USD 40 million in Evosep, a proteomics technology company, to improve the quality of life and patient care by leveraging the power of LC-MS for drug discovery and developing protein-based clinical diagnostics that involve multiple protein biomarkers.

Furthermore, the integration of other omics technologies with proteomics holds tremendous potential in enhancing the capabilities of identifying & treating complex diseases. This integration creates a vast array of opportunities for proteomics service providers & contributes to the expansion of the market in the years to come.

“In case you missed it, we are currently revising our reports. Click on the below to get the latest research data with forecasts for years 2024 to 2030, including market size, industry trends, and competitive analysis. It wouldn't take long for the team to deliver the most recent version of the report.”

Access Free Sample Report - https://www.marknteladvisors.com/query/request-sample/apac-proteomics-market.html                

Scope of the Report and Asia-Pacific Proteomics Market Segmentation

By Technology

-Spectroscopy

--Mass Spectroscopy

--NMR Spectroscopy

--CD Spectroscopy

-Chromatography

--HPLC Chromatography

--Affinity Chromatography

--Supercritical Fluid Chromatography

--Ion Exchange Chromatography

-Electrophoresis

--Gel Electrophoresis

--Capillary Electrophoresis

-Protein Microarray

--Biochip

---Lab-on-Chip

---Protein Chip

-Microarray Instrument

--Integrated System

--Microarray Scanner

--Arrayers

-Crystallography

-Surface Plasma Resonance

-Fractionation

-Others (X-Ray Crystallography, Enzyme-linked Immunosorbent Assay, etc.)

  • The Spectroscopy segment held a sizeable share in the Asia-Pacific Proteomics Market.

By Reagent

-Immunoassay Reagents

-Spectroscopy Reagents

-Chromatography Reagents

-Protein Microarray Reagents

-X-Ray Crystallography Reagents

-Electrophoresis Reagents

-Protein Fractionation Reagents

-Others (Glycobiology Agents, Phos-tag, etc.)

By Offering

-Core Proteomics Service

--Protein Identification

--Protein Characterization

--Quantitative proteomics

--Protein Purification

--Protein Separation

--Protein Sequencing

--Custom Assay

-Software & Services

--Bioinformatics Services

--Bioinformatics Tools

--Bioinformatics Database

By Indication

-Oncology

-Infectious Diseases

-Diabetes

-Neurological Disorder

-Autoimmune Diseases

-Cardiovascular Diseases

-Others (Gastrointestinal, Lung disease, etc.)

By End-User

-Hospitals

-Clinical Laboratories

-Pharmaceutical & Biotechnology Companies

-Academic Research Laboratories

Top leading companies in the Asia-Pacific Proteomics Market includes:

Agilent Technologies Inc., Bio-Rad Laboratories Inc., Danaher Corporation, GE Healthcare, Thermofisher Scientific Inc., Merck KgaA, Promega Corporation, Bruker Corporation, Waters Corporation, MRM Proteomics Inc., Luminex Inc., Perkin Elmer Inc., and others

For more detailed information about the Asia-Pacific Proteomics market report, click here – https://www.marknteladvisors.com/research-library/apac-proteomics-market.html                                          

Geographical analysis:

China

India

Japan

South Korea

Australia

Singapore

Rest of the Asia-Pacific

  • China has emerged as a major player in the Proteomics Market

Note: If you require specific information not covered in the current report, we can provide it through customized option

Related Reports: -

https://www.openpr.com/news/3396952/global-workplace-safety-market-reach-usd-14-9-billion-in-2023         

https://www.openpr.com/news/3391034/global-pea-protein-market-size-hits-usd-1-4-billion-mark-in-2022         

https://www.openpr.com/news/3391023/global-green-hydrogen-market-expected-to-witness-a-15-7-cagr  

Why choose Us?

MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.

For Media Inquiries, Please Contact:

Call: +1 628 895 8081 | +91 120 4278433

Email: [email protected]

Sales Office: 564 Prospect St, B9, New Haven, Connecticut, USA-06511

Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India